Orthofix Medical Inc. (OFIX) Financial Statements
Orthofix Medical Inc. (OFIX) reported trailing twelve-month revenue of $833.2M (up 3.0% year on year) and net income of -$61.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$27.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OFIXOrthofix Medical Inc.Follow OFIX — free
—
Price chart with a free account
- Market cap
- 399.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 435.5 | 440.2 | 397.6 | 402.3 | 396.5 | 409.8 | 433.8 | 453.0 | 460.0 | 406.6 | 464.5 | 460.7 | 746.6 | 799.5 | 822.3 | 833.2 | |
| Gross profit | 339.1 | 339.5 | 290.7 | 303.4 | 310.0 | 321.9 | 340.8 | 356.4 | 359.3 | 304.7 | 349.6 | 337.2 | 486.3 | 545.9 | 566.0 | 594.1 | |
| Research & development | 22.9 | 28.6 | 26.8 | 25.0 | 26.4 | 28.8 | 29.7 | 33.2 | 34.6 | 39.1 | 49.6 | 49.1 | 80.2 | 73.6 | 65.8 | 61.4 | |
| Operating income | 6.6 | 74.9 | -11.2 | 17.1 | 9.3 | 21.1 | 40.8 | 30.1 | -18.8 | -6.3 | -8.3 | -13.3 | -139.1 | -84.6 | -81.4 | -39.1 | |
| Pre-tax income | -1.4 | 69.1 | -10.6 | 12.5 | 8.5 | 19.0 | 36.4 | 22.9 | -27.0 | -0.4 | -13.5 | -17.7 | -148.7 | -123.9 | -90.8 | -60.3 | |
| Income tax | 14.4 | 23.9 | 7.6 | 16.2 | 10.8 | 15.5 | 29.1 | 9.1 | 1.4 | -2.9 | 24.9 | 2.0 | 2.7 | 2.1 | 1.4 | 1.4 | |
| Net income | -17.7 | 42.9 | -28.8 | -8.5 | -2.8 | 3.1 | 6.2 | 13.8 | -28.5 | 2.5 | -38.4 | -19.7 | -151.4 | -126.0 | -92.2 | -61.7 | |
| Diluted EPS ($) | -0.97 | 2.21 | -1.54 | -0.46 | -0.15 | 0.17 | 0.34 | 0.72 | -1.51 | 0.13 | -1.95 | -0.98 | -4.12 | -3.30 | -2.33 | -1.53 | |
| Diluted shares (mn) | 18.2 | 19.4 | 18.7 | 18.5 | 18.8 | 18.5 | 18.5 | 18.9 | 18.9 | 19.4 | 19.7 | 20.1 | 36.7 | 38.1 | 39.6 | — |
USD millions · SEC XBRL
Orthofix Medical Inc. — questions
- What is Orthofix Medical Inc.'s revenue?
- $833.2M over the twelve months to 2026-06-30, up 3.0% year on year, from its 10-Q and 10-K filings.
- What is Orthofix Medical Inc.'s net income?
- -$61.7M over the twelve months to 2026-06-30.
- What is Orthofix Medical Inc.'s free cash flow?
- -$27.8M over the twelve months to 2026-06-30.
- What are Orthofix Medical Inc.'s diluted earnings per share?
- $-1.53 over the twelve months to 2026-06-30.
Every figure on this page comes from Orthofix Medical Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.